Instituto de Medicina Molecular – João Lobo Antunes, University of Lisbon
Bruno Silva-Santos is Vice-Director of Instituto de Medicina Molecular (iMM Lisboa), and Associate Professor of the Faculty of Medicine of the University of Lisbon. He did his PhD and postdoctoral training in Immunology at Cancer Research UK – The London Research Institute and King’s College London, respectively. As an independent group leader at iMM Lisboa, Bruno Silva-Santos received Starting and Consolidator Grants from the European Research Council (ERC) and Installation and Young Investigator Grants from the European Molecular Biology Organization (EMBO). His research is dedicated to T cell responses to tumours, having dissected novel molecular mechanisms of T cell differentiation and tumour cell recognition, published in 70 international peer-reviewed papers. His translational work was recognized with various awards; and led to a start-up company focused on cancer immunotherapy, Lymphact, where he heads the Scientific Council. He serves as editor for 6 peer-reviewed journals, including OncoImmunology, Frontiers in Immunology and Oncology, and European Journal of Immunology.